Cordis Opens Facility in Ireland

Dec. 3, 2008
Plant will make the company's newest stent technology.

Medical device manufacturer Cordis Corp. opened a high-tech 180,000-square-foot facility in Cashel, Ireland, where the Johnson & Johnson subsidiary will make next-generation drug-eluting stents, the company said Dec. 2.

In addition to production capabilities, the facility features a development laboratory and a finished-goods testing facility.

The plant currently employs 100 people during its first phase of development. When fully operational by late 2009 or early 2010, the facility will employ approximately 450 additional people, according to company spokesman Christopher Allman.

The new stent, known as the NEVO Sirolimus-eluting Coronary Stent, is currently being evaluated in two major clinical trials around the world, the company said. It's designed for treatment of patients suffering from coronary artery disease and utilizes a technology that incorporates hundreds of small reservoirs, each acting as a depot into which drug-polymer compositions are loaded. The design allows drug delivery from an implant, the surface of which is 75% polymer-free bare metal upon insertion and becomes fully bare metal following drug delivery and polymer bioresorption in approximately three months.

Johnson & Johnson has five facilities in Ireland and has been operating in the country for more than 50 years.

About the Author

Jonathan Katz | Former Managing Editor

Former Managing Editor Jon Katz covered leadership and strategy, tackling subjects such as lean manufacturing leadership, strategy development and deployment, corporate culture, corporate social responsibility, and growth strategies. As well, he provided news and analysis of successful companies in the chemical and energy industries, including oil and gas, renewable and alternative.

Jon worked as an intern for IndustryWeek before serving as a reporter for The Morning Journal and then as an associate editor for Penton Media’s Supply Chain Technology News.

Jon received his bachelor’s degree in Journalism from Kent State University and is a die-hard Cleveland sports fan.

Sponsored Recommendations

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!